Effects of Combined Neuromuscular Electrical Stimulation Robot and Trans-Spinal Electrical Stimul… (NCT07112911) | Clinical Trial Compass
RecruitingNot Applicable
Effects of Combined Neuromuscular Electrical Stimulation Robot and Trans-Spinal Electrical Stimulation in Poststroke Rehabilitation
Hong Kong65 participantsStarted 2025-07-28
Plain-language summary
The purpose of this study is to investigate the clinical efficacy and neurological progress of combined training using trans-spinal electrical stimulation (tsES) and neuromuscular electrical stimulation (NMES)-driven robotics on upper limb rehabilitation after stroke
Who can participate
Age range
25 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects in the chronic stage (start from 6 months after the onset of stroke) with a pure unilateral motor paresis after a stroke (ischemic or hemorrhagic);
* Sufficient cognition to follow simple instructions as well as understand the content and purpose of the experiment (Mini-Mental State Examination (MMSE) score\>23);
* Be able to sit up for 60 minutes (with or without assistance);
* Muscle strength graded from 1 to 3 in biceps brachii, triceps brachii, extensor carpi radialis, flexor carpi radialis, and abductor pollicis brevis in the affected side.
* The voluntary electromyographic signals of the wrist extensor and wrist flexor muscle groups can be detected.
Exclusion Criteria:
* Patients with secondary stroke;
* Severe dysphasia (either expressive or comprehensive) with inadequate communication;
* Any additional medical or psychological condition affecting their ability to comply with the study protocol;
* History of other neurological disease, psychiatric disorder, including alcoholism and substance abuse;
* currently pregnant;
* epilepsy;
* pacemaker implantation or deep brain stimulation;
* involved in drug studies, other clinical trials, or concurrent medication/occupational/physical treatments on the upper limb;
* skin disease at the area of the electrodes;
* High hypertension and cannot maintain normal blood pressure despite daily intake of antihypertensive medication.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Fugl-Meyer Assessment Scale after training
Timeframe: Within 1 week before the start of training Within 1 week after the completion of training 3 months after the completion of training